AI-Reviewed Research, Clinical Excellence & Evidence-Based Practice in Aesthetic Medicine— Curated and reviewed by practising aesthetic clinicians
Regulatory updates, product alerts, peer-reviewed research highlights, and HSI announcements — filtered by region. Editorial commentary, not promotional.
Ireland’s Health Products Regulatory Authority has expanded post-market surveillance requirements for hyaluronic-acid fillers and botulinum toxin products distributed in the Republic, with clinicians encouraged to report adverse events through the online portal.
The Health Information and Quality Authority has opened a consultation that, for the first time, explicitly references non-surgical aesthetic procedures within proposed national standards for private healthcare settings.
Industry news is curated by the HSI editorial board. Items summarise external regulatory, product, and peer-reviewed developments and link to primary sources. They do not constitute clinical guidance. For peer-reviewed analysis, see the main journal.